Policy Points This article reconceptualizes our understanding of the opioid epidemic and proposes six strategies that address the epidemic's social roots. In order to successfully reduce drug-related mortality over the long term, policymakers and public health leaders should develop partnerships with people who use drugs, incorporate harm reduction interventions, and reverse decades of drug criminalization policies. CONTEXT: Drug overdose is the leading cause of injury-related death in the United States. Synthetic opioids, predominantly illicit fentanyl and its analogs, surpassed prescription opioids and heroin in associated mortality rates in 2016. Unfortunately, interventions fail to fully address the current wave of the opioid epidemic and often omit the voices of people with lived experiences regarding drug use. Every overdose death is a culmination of a long series of policy failures and lost opportunities for harm reduction. METHODS: In this article, we conducted a scoping review of the opioid literature to propose a novel framework designed to foreground social determinants more directly into our understanding of this national emergency. The "continuum of overdose risk" framework is our synthesis of the global evidence base and is grounded in contemporary theories, models, and policies that have been successfully applied both domestically and internationally. FINDINGS: De-escalating overdose risk in the long term will require scaling up innovative and comprehensive solutions that have been designed through partnerships with people who use drugs and are rooted in harm reduction. CONCLUSIONS: Without recognizing the full drug-use continuum and the role of social determinants, the current responses to drug overdose will continue to aggravate the problem they are trying to solve.
Policy Points This article reconceptualizes our understanding of the opioid epidemic and proposes six strategies that address the epidemic's social roots. In order to successfully reduce drug-related mortality over the long term, policymakers and public health leaders should develop partnerships with people who use drugs, incorporate harm reduction interventions, and reverse decades of drug criminalization policies. CONTEXT: Drug overdose is the leading cause of injury-related death in the United States. Synthetic opioids, predominantly illicit fentanyl and its analogs, surpassed prescription opioids and heroin in associated mortality rates in 2016. Unfortunately, interventions fail to fully address the current wave of the opioid epidemic and often omit the voices of people with lived experiences regarding drug use. Every overdose death is a culmination of a long series of policy failures and lost opportunities for harm reduction. METHODS: In this article, we conducted a scoping review of the opioid literature to propose a novel framework designed to foreground social determinants more directly into our understanding of this national emergency. The "continuum of overdose risk" framework is our synthesis of the global evidence base and is grounded in contemporary theories, models, and policies that have been successfully applied both domestically and internationally. FINDINGS: De-escalating overdose risk in the long term will require scaling up innovative and comprehensive solutions that have been designed through partnerships with people who use drugs and are rooted in harm reduction. CONCLUSIONS: Without recognizing the full drug-use continuum and the role of social determinants, the current responses to drug overdose will continue to aggravate the problem they are trying to solve.
Authors: Christopher Sterrett; Joseph Brownfield; Carrie S Korn; Mark Hollinger; Sean O Henderson Journal: Am J Emerg Med Date: 2003-01 Impact factor: 2.469
Authors: Ju Nyeong Park; Glenna Urquhart; Miles Morris; Rejwi Dahal; Saba Rouhani; Susan G Sherman Journal: J Addict Med Date: 2022-02-04 Impact factor: 4.647
Authors: Catherine Tomko; Kristin E Schneider; Saba Rouhani; Glenna J Urquhart; Ju Nyeong Park; Miles Morris; Susan G Sherman Journal: Addict Behav Date: 2021-12-20 Impact factor: 4.591
Authors: Sabriya L Linton; Abigail Winiker; Kayla N Tormohlen; Kristin E Schneider; Grace McLain; Susan G Sherman; Renee M Johnson Journal: Prev Sci Date: 2021-04-07
Authors: Ju Nyeong Park; Kristin E Schneider; David Fowler; Susan G Sherman; Ramin Mojtabai; Paul S Nestadt Journal: J Addict Med Date: 2022 Jan-Feb 01 Impact factor: 3.702
Authors: Jessica C Smith; Leigh Alderman; Brandon K Attell; Wendy Avila Rodriguez; Jana Covington; Brigitte Manteuffel; Ann M DiGirolamo; Susan M Snyder; Karen Minyard Journal: Front Psychol Date: 2021-06-29
Authors: Ju Nyeong Park; Jill Owczarzak; Glenna Urquhart; Miles Morris; Noelle P Weicker; Saba Rouhani; Susan G Sherman Journal: AIDS Behav Date: 2021-07-21